Key challenges with GLP-1s in 2025 Adherence issues and long-term use Adherence to GLP-1s remains a significant challenge despite their proven efficacy in weight management and type 2 diabetes
30% of people taking Wegovy lost 20% or more weight, compared to 2% of people taking placebo, in a supportive measure
3 Caldow MK, Ham DJ, Chee A, Trieu J, Naim T, Stapleton DI, Swiderski K, Lynch GS, Koopman R
Mistake #5: Waiting Until You Notice Muscle Loss The Problem: "I'll start lifting weights if I notice I'm losing muscle
(Expert analysis citing 6.7 bpm figure) Eli Lilly press release: TRIUMPH-4 Phase 3 topline results
It coats the cheeks, tongue, and teeth, helps you swallow comfortably, and keeps the mouth balanced